临床试验中糖尿病黄斑水肿患者中央亚区厚度波动与视力结局恶化的关联
该研究基于两项大型临床试验的事后分析,纳入1197只眼,用研究期间所有记录的中央亚区厚度(CST)的标准差(SD)量化波动。按CST SD四分位分组后,在调整基线视力、基线CST、晶状体状态、HbA1c和治疗组别后,两项试验中不同CST SD四分位组间视力存在显著差异。结论认为CST大幅波动可能预示糖尿病黄斑水肿(DME)患者2年视力结局更差。
要点
- CST波动用研究期间所有CST记录的标准差(SD)量化,并按四分位分组分析。
核心结论
- CST大幅波动可能预示DME患者2年视力结局更差。
研究设计与样本
- 基于两项大型临床试验数据库的事后分析临床队列研究,共纳入1197只眼。
- 纳入标准为至少有3次CST记录且随访1年时有视力数据。
- 用每只眼研究期间所有CST记录的标准差(SD)量化CST波动,并按CST SD四分位分组。
主要发现
- 在调整基线视力、基线CST、晶状体状态、HbA1c和治疗组别后,两项试验中不同CST SD四分位组间视力均存在显著差异。
关键数值与推荐
- CST波动定义为研究期间所有记录CST的标准差(SD)。
- 视力结局按CST SD四分位分层,评估第1年和第2年视力。
临床怎么用
- 在DME随访中关注CST的波动幅度,而不仅看单次CST值。
- CST波动较大的患者可能需更密切随访和个体化治疗策略。
局限性
- 本研究为临床试验数据库的事后分析。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study examines the relationship between fluctuations in central subfield thickness (CST) and visual acuity (VA) in patients with diabetic macular edema (DME) using data from 2 large clinical trials. DESIGN: Clinical cohort study using post hoc analysis of clinical trial databases. METHODS: Standard deviation (SD) of all recorded CSTs for each patient during the study period were used to quantify the fluctuations in CST. Patients from each protocol were grouped into quartiles based on the CST SD. Eyes with at least 3 CSTs and VA at 1 year were included. The main outcome measures were VA at 1 and 2 years for each protocol, stratified by SD quartile. RESULTS: A total of 1197 eyes were included in the analysis. There were significant VA differences based on CST SD quartile for both protocols while adjusting for mean baseline VA, baseline CST, lens status, hemoglobin A1c, and treatment arm. At week 52 in protocol T, the difference between the first and fourth quartiles was -1.61 Early Treatment Diabetic Retinopathy Study letters (95% confidence interval [CI] -3.52 to 0.30, P = .0986). At week 104, this difference was -3.59 letters (95% CI -6.17 to -1.00, P = .0066). In protocol V, at week 52, the difference between the first and fourth quartiles was -3.04 letters (95% CI -4.18 to -1.91, P < .0001). At week 104, this difference was -2.35 letters (95% CI -3.58 to -1.13, P = .0005). CONCLUSION: Large fluctuations in CST may portend worse VA outcomes at the 2-year end point in patients with DME.
引用
- Starr MR, Salabati M, Mahmoudzadeh R, et al. Fluctuations in Central Subfield Thickness Associated With Worse Visual Outcomes in Patients With Diabetic Macular Edema in Clinical Trial Setting. Am J Ophthalmol. 2021. PMID: 34283986. doi:10.1016/j.ajo.2021.06.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。